Literature DB >> 10398608

Reasons for not seeing drug representatives.

D Griffith.   

Abstract

Keywords:  Health Care and Public Health; Professional Patient Relationship

Mesh:

Substances:

Year:  1999        PMID: 10398608      PMCID: PMC1116222          DOI: 10.1136/bmj.319.7202.69

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Beyond conflict of interest. Transparency is the key.

Authors:  R Smith
Journal:  BMJ       Date:  1998-08-01

2.  General practitioners' workload in primary care led NHS. Practice's consultation rates have increased by three quarters in past 25 years.

Authors:  I Sidford
Journal:  BMJ       Date:  1997-08-30

3.  Long term pharmacotherapy of depression. Can reduce relapses and recurrences in major depression.

Authors:  J G Edwards
Journal:  BMJ       Date:  1998-04-18

Review 4.  Interactions between physicians and the pharmaceutical industry: what does the literature say?

Authors:  J Lexchin
Journal:  CMAJ       Date:  1993-11-15       Impact factor: 8.262

5.  Selective serotonin reuptake inhibitors for depression?

Authors: 
Journal:  Drug Ther Bull       Date:  1993-07-19

6.  Market penetration of new drugs in one United Kingdom region: implications for general practitioners and administrators.

Authors:  H McGavock; C H Webb; G D Johnston; E Milligan
Journal:  BMJ       Date:  1993-10-30

7.  Doctors and detailers: therapeutic education or pharmaceutical promotion?

Authors:  J Lexchin
Journal:  Int J Health Serv       Date:  1989       Impact factor: 1.663

  7 in total
  5 in total

1.  Reasons for not seeing drug representatives. They should be seen because they are a good resource.

Authors:  R Tiner
Journal:  BMJ       Date:  1999-10-09

2.  So much time for so little: Italy's pharmaceutical industry and doctors' information needs.

Authors:  E Maestri; G Furlani; F Suzzi; A Campomori; G Formoso; N Magrini
Journal:  BMJ       Date:  2000-01-01

3.  Selling drugs to the public--should the UK follow the example of the US?

Authors:  John Frey
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

4.  Selling drugs to doctors--it's marketing, not education.

Authors:  Richelle Cooper; Jerome Hoffman
Journal:  Br J Gen Pract       Date:  2002-02       Impact factor: 5.386

5.  The company we keep: why physicians should refuse to see pharmaceutical representatives.

Authors:  Howard Brody
Journal:  Ann Fam Med       Date:  2005 Jan-Feb       Impact factor: 5.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.